New York Health Care
OTCPK:BBAL
$ 0,00
$0,00 (0,00%)
0,00 $
$0,00 (0,00%)
End-of-day quote: 02/22/2024

New York Health Care Stock Value

The current analyst recommendation for OTCPK:BBAL is: sf_Data Unavailable.
-

New York Health Care Company Info

EPS Growth 5Y
0,00%
Market Cap
$0,00 B
Long-Term Debt
$N/A
Short Interest
0,03%
Annual earnings
N/A
Dividend
$0,00
Dividend Yield
0,00%
Founded
1983
Industry
ISIN Number

Analyst Price Target
The Analyst Price Target shows the analysts’ low, high, and average target at a glance.

There are currently no price targets available for this stock.

In the last five quarters, New York Health Care’s Price Target has risen from $8,00 to $8,00 - a 0,00% increase.

Top growth stocks in the health care sector (5Y.)

What does New York Health Care do?

New York Health Care, Inc., a development stage biopharmaceutical company, engages in the identification, licensing, and development of treatments for gastrointestinal disorders, such as pouchitis, irritable bowel syndrome (IBS), Crohn’s disease, ulcerative colitis, celiac disease, and C. difficile infections. Segments The company operates through two segments, including Biobalance Business; and Home Health Care Business. Biobalance Business Products PROBACTRIX: PROBACTRIX is a non-pathogen...
×